2 results
Approved WMOCompleted
The Purpose of the study is to investigate the clinical feasibility of the TW15 and TW22.
Approved WMOWill not start
Primary Objectives* Phase 1b lead-in: To assess safety and tolerability of a single dose level of avelumab in combination withincreasing dose levels of other immune modulators in combination with a single doselevel of avelumab in patients with…